• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.3
  • 漲跌
    ▼0.5
  • 漲幅
    -0.84%
  • 成交量
    24張
  • 產業
    上櫃 生技醫療類股▲0.61%

  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
東生華 (8432)籌碼相關－富邦-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

富邦-台中 券商分點個股進出

富邦-台中 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/15258.3000.0057.602862.32%
2025/01/09161.6000.0061.001911.09%
2024/12/31560.8000.0061.3051363.67%
2024/12/0900.0010.162.9162.80-10.1142-7.06%
2024/11/2000.00564.0063.80-5148-3.36%
2024/11/19165.00163.8063.8001460.00%
2024/11/0700.000.163.5064.40-0.1133-0.07%
2024/11/0100.00264.8065.10-2147-1.35%
2024/10/2900.00165.2064.50-1150-0.66%
2024/10/220.164.3000.0064.800.11670.04%
2024/10/1100.00762.7062.50-7155-4.51%
2024/10/0900.00564.2062.20-5153-3.25%
2024/10/0800.000.165.5063.20-0.1150-0.03%
2024/10/0100.000.158.6058.60-0.1135-0.06%
2024/07/30267.50267.6566.2002310.00%
2024/07/1900.000.161.8061.60-0.1224-0.04%
2024/07/1600.00063.0063.2002350.00%
2024/07/080.263.9000.0063.500.22290.08%
2024/07/05267.55267.6567.5002220.00%
2024/07/0200.000.168.6069.20-0.1226-0.02%
2024/06/2500.00069.0068.3002270.00%
2024/06/181.264.43163.9064.400.22200.09%
2024/06/170.163.9000.0063.400.12190.02%
2024/06/0700.00166.4066.30-1217-0.46%
2024/06/0600.00065.1067.1002170.00%
2024/06/03164.0000.0064.9012220.45%
2024/05/1400.00165.5065.60-1323-0.31%
2024/05/0900.00068.0067.1003130.00%
2024/05/0800.000.163.3364.40-0.1299-0.02%
2024/05/0700.00062.2062.3002840.00%
2024/03/20055.2000.0055.4002490.00%
2024/03/1500.00155.8054.60-1250-0.40%
2024/03/07056.6000.0056.6002450.01%
2024/03/06059.6000.0058.0002380.01%
2024/03/0400.00164.5061.10-1226-0.44%
2024/03/0100.00064.2063.8002200.00%
2024/02/2700.00464.2064.30-4216-1.85%
2024/02/2600.00162.5061.20-1205-0.49%
2024/02/23463.08261.2061.0022020.99%
2024/02/22360.8300.0060.0031931.55%
2024/02/2100.00559.5261.90-5182-2.74%
2024/02/19456.7800.0056.0041612.47%
2024/02/1600.00156.9057.20-1161-0.62%
東生華加速16項新品專案開發 目標未來5年營收翻倍Anue鉅亨－2024/12/20
...詳全文
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨－2024/08/26
...詳全文
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨－2024/07/22
...詳全文
東生華 相關文章